We are studying the effects of CART19 cells in patients with relapsed or refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma. This research aims to explore new treatment possibilities for these challenging conditions.
Health conditions and diseases that the clinical trial is designed to study and treat.
Recurrent Acute Lymphoblastic Leukaemia (ALL) is a type of cancer that affects the blood and bone marrow, characterized by the rapid growth of immature white blood cells. This condition can return after treatment or may not respond to initial therapies.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.